Top Markets
#1 Celer Network Celer Network +49.10%
#2 Gravity Gravity +24.44%
#3 Galxe Galxe +23.88%
#4 ICON ICON +13.39%
#5 MemeCore MemeCore +13.25%
#6 Cartesi Cartesi +12.87%
#7 Zilliqa Zilliqa +10.95%
#8 Genius Genius +10.65%
#9 Ontology Gas Ontology Gas +9.33%
#10 CyberDEX CyberDEX +7.13%
Coin of the day
Celer Network Celer Network
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Fusion Antibodies plc Fusion Antibodies plc

Fusion Antibodies plc

FAB
Rangering i aksjer #40225
Fusion Antibodies plc operates as a contract research organization (CRO),... Fusion Antibodies plc operates as a contract research organization (CRO), providing specialized services in the research, development, and manufacturing of recombinant proteins and antibodies. The company primarily focuses on solutions for oncology and infectious diseases, serving a global clientele across the United Kingdom, broader Europe, and North America. Its comprehensive suite of offerings encompasses monoclonal antibody discovery and advancement, antibody sequencing and engineering, and a distinct platform for antibody humanization and rational affinity maturation. Additionally, Fusion Antibodies provides recombinant protein expression, stable cell line development, and cGMP-compliant scale-up services. Clients span the pharmaceutical, biotechnology, and diagnostic sectors. Notably, the company maintains a collaborative partnership with Celonic AG. Established in 2000, Fusion Antibodies plc is headquartered in Belfast, United Kingdom.
Aksjekurs
$0.1559364
Sist synkronisert: 2026-09-18
Markedsverdi
$195.17K
Endring (1 dag)
6.60%
Endring (1 år)
-30.91%
Land
GB
Handel Fusion Antibodies plc (FAB)

Kategori

Healthcare
Antall utestående aksjer for Fusion Antibodies plc (FAB)
Antall utestående aksjer per September 2025: 113.21M
Ifølge Fusion Antibodies plc sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 113.21M. Ved slutten av March 2024 hadde selskapet 55.56M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Fusion Antibodies plc (FAB) fra 2013 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
2026 (TTM) 113.21M 18.07%
2025 95.88M 72.58%
2024 55.56M 113.55%
2023 26.01M 0.27%
2022 25.95M 1.91%
2021 25.46M 15.24%
2020 22.09M 0.00%
2019 22.09M 37.07%
2018 16.12M -27.04%
2017 22.09M 0.00%
2016 22.09M 0.00%
2015 22.09M 0.00%
2014 22.09M 0.00%
2013 22.09M 0.00%
Utestående aksjer for lignende selskaper eller konkurrenter
Selskap Utestående aksjer Forskjell Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 124.27%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -45.07%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M 249.79%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M 323.03%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH